Low Plasma Adiponectin Levels and Risk of Colorectal Cancer in Men: A Prospective Study
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Adiponectin is an insulin-sensitizing hormone secreted by adipocytes. Levels of adiponectin are inversely associated with adiposity and insulin resistance. Because both adiposity and insulin resistance have been associated with risk of colorectal cancer, we hypothesized that adiponectin is associated with colorectal carcinogenesis. METHODS: We evaluated the association between adiponectin and colorectal cancer among 18 225 men in the Health Professionals Follow-up Study who provided blood samples in 1994. Between blood collection and January 31, 2002, 179 incident colorectal cancer cases occurred. Each case patient was matched to two control subjects on year of birth and date of blood draw. Information on lifestyle factors and diet was collected using biennial questionnaires and food frequency questionnaires. Logistic regression models were used to estimate relative risks (RRs) and confidence intervals (CIs). All statistical tests were two-sided. RESULTS: We observed a statistically significant inverse association between plasma adiponectin levels and risk of colorectal cancer (for the highest quintile [Q5] versus the lowest quintile [Q1], RR = 0.42, 95% CI = 0.23 to 0.78; P(trend) = .01). The association was only slightly attenuated after adjustment for body mass index (Q5 versus Q1, RR = 0.48, 95% CI = 0.25 to 0.90; P(trend) = .04) or for body mass index and other major risk factors for colorectal cancer (family history, physical activity, multivitamin use, smoking, alcohol, aspirin use, history of endoscopy, dietary calcium, folate, vitamin E, and vitamin D; Q5 versus Q1, multivariable RR = 0.50, 95% CI = 0.26 to 0.97; P(trend) = .08). Relative risks were not linear in any of the analyses; the second quintile had a lower relative risk than the lowest quintile, but further decreases in risk were not evident with increasing levels of adiponectin. CONCLUSIONS: In this prospective nested case-control study, men with low plasma adiponectin levels had a higher risk of colorectal cancer than men with higher levels. More prospective observational studies, particularly in women, and mechanistic studies are required to fully understand the relationship between adiponectin and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Reproducibility and validity of a semiquantitative food frequency questionnaire
WILLETT, W. C., SAMPSON, L., STAMPFER, M. J., ROSNER, B., BAIN, C., WITSCHI, J., HENNEKENS, C. H., & SPEIZER, F. E. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114086 · Cited by 4,274
Self-citationA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
Self-citationDiet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1723 · Cited by 1,297
Percentage Points for a Generalized ESD Many-Outlier Procedure
Rosner, B. (1983) · Technometrics · doi:10.1080/00401706.1983.10487848 · Cited by 1,268
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,134
The role of the novel adipocyte-derived hormone adiponectin in human disease
Diez, J., & Iglesias, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480293 · Cited by 1,114
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., & Scherer, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207198200 · Cited by 1,086
Validity of Self-Reported Waist and Hip Circumferences in Men and Women
Rimm, E. B., Stampfer, M. J., Colditz, G. A., Chute, C. G., Litin, L. B., & Willett, W. C. (1990) · Epidemiology · doi:10.1097/00001648-199011000-00009 · Cited by 1,015
Self-citationPhysical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men
Giovannucci, E., Ascherio, A., Rimm, E. B., Colditz, G. A., Stampfer, M. J., & Willett, W. C. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-5-199503010-00002 · Cited by 1,013
Self-citationInsulin, Insulin-Like Growth Factors and Colon Cancer: A Review of the Evidence
Giovannucci, E. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.11.3109s · Cited by 959
Self-citationCarey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
TRUJILLO, M. E., & SCHERER, P. E. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01426.x · Cited by 769
Bråkenhielm, E., Veitonmäki, N., Cao, R., Kihara, S., Matsuzawa, Y., Zhivotovsky, B., Funahashi, T., & Cao, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308671100 · Cited by 732
Plasma Adiponectin Concentrations Predict Insulin Sensitivity of Both Glucose and Lipid Metabolism
Tschritter, O., Fritsche, A., Thamer, C., Haap, M., Shirkavand, F., Rahe, S., Staiger, H., Maerker, E., Häring, H., & Stumvoll, M. (2003) · Diabetes · doi:10.2337/diabetes.52.2.239 · Cited by 585
Adiponectin and Breast Cancer Risk
Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D. M., Papadiamantis, Y., Markopoulos, C., Spanos, E., Chrousos, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031804 · Cited by 533
Self-citationSandhu, M. S. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.972 · Cited by 496
Belanger, C. F., Hennekens, C. H., Rosner, B., & Speizer, F. E. (1978) · The American Journal of Nursing · doi:10.2307/3462013 · Cited by 444
AMPK, the metabolic syndrome and cancer
Luo, Z., Saha, A. K., Xiang, X., & Ruderman, N. B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.011 · Cited by 426
Giovannucci, E. L., Pollak, M., Platz, E. A., Willett, W. C., Stampfer, M. J., Majeed, N., Colditz, G. A., Speizer, F. E., & Hankinson, S. E. (2000) · PubMed · Cited by 426
Self-citationProspective Study of Adult Onset Diabetes Mellitus (Type 2) and Risk of Colorectal Cancer in Women
Hu, F. B., Manson, J. E., Liu, S., Hunter, D., Colditz, G. A., Michels, K. B., Speizer, F. E., & Giovannucci, E. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.542 · Cited by 423
Self-citationLeisure-Time Physical Activity, Body Size, and Colon Cancer in Women
Martinez, M. E., Giovannucci, E., Spiegelman, D., Willett, W. C., Hunter, D. J., & Colditz, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.948 · Cited by 419
Self-citationShetty, G. K., Economides, P. A., Horton, E. S., Mantzoros, C. S., & Veves, A. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2450 · Cited by 415
Self-citationThe Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371
Self-citationA Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
Ma, J., Giovannucci, E., Pollak, M., Leavitt, A., Tao, Y., Gaziano, J. M., & Stampfer, M. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh082 · Cited by 329
Self-citationCENTENO, A. M. (1951) · PubMed · Cited by 272
Circulating Adiponectin and Endometrial Cancer Risk
Dal Maso, L., Augustin, L. S. A., Karalis, A., Talamini, R., Franceschi, S., Trichopoulos, D., Mantzoros, C. S., & La Vecchia, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031716 · Cited by 256
Self-citationPlasma Adiponectin and Gastric Cancer
Ishikawa, M., Kitayama, J., Kazama, S., Hiramatsu, T., Hatano, K., & Nagawa, H. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.466.11.2 · Cited by 253
Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece
Petridou, E., Mantzoros, C., Dessypris, N., Koukoulomatis, P., Addy, C., Voulgaris, Z., Chrousos, G., & Trichopoulos, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021209 · Cited by 234
Self-citationWei, E. K., Ma, J., Pollak, M. N., Rifai, N., Fuchs, C. S., Hankinson, S. E., & Giovannucci, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0661 · Cited by 225
Self-citationIGF-I and IGF-II in relation to colorectal cancer
Manousos, O., Souglakos, J., Bosetti, C., Tzonou, A., Chatzidakis, V., Trichopoulos, D., Adami, H.-O., & Mantzoros, C. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990924)83:1<15::aid-ijc4>3.0.co;2-y · Cited by 188
Self-citationMa, J., Pollak, M., Giovannucci, E., Chan, J. M., Tao, Y., Hennekens, C., & Stampfer, M. J. (2000) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(00)90013-3 · Cited by 175
Self-citationBody size and the risk of colon cancer in a large case-control study
Caan, B., Coates, A., Slattery, M., Potter, J., Jr, C. Q., & Edwards, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800561 · Cited by 160
Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year
Pischon, T., Hotamisligil, G. S., & Rimm, E. B. (2003) · Clinical Chemistry · doi:10.1373/49.4.650 · Cited by 147
Validity and reproducibility of a physical activity questionnaire in women
CHASAN-TABER, L., BIANCA ERICKSON, J., NASCA, P. C., CHASAN-TABER, S., & FREEDSON, P. S. (2002) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200206000-00013 · Cited by 64
Thamer, C., Haap, M. M., Bachmann, O. P., Nieden, T. Z., Tschritter, O., Stefan, N., Fritsche, A., Jacob, S., Stümvoll, M., & Häring, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1430-7 · Cited by 16
Cited by
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
Adams, L. A., Anstee, Q. M., Tilg, H., & Targher, G. (2017) · Gut · doi:10.1136/gutjnl-2017-313884 · Cited by 1,174
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Bardou, M., Barkun, A. N., & Martel, M. (2013) · Gut · doi:10.1136/gutjnl-2013-304701 · Cited by 815
Obesity and cancer—mechanisms underlying tumour progression and recurrence
Park, J., Morley, T. S., Kim, M., Clegg, D. J., & Scherer, P. E. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.94 · Cited by 790
Metadata
- Authors
- Wei, E. K., Giovannucci, E., Fuchs, C. S., Willett, W. C., & Mantzoros, C. S.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-11-16
- Volume
- 97
- Issue
- 22
- Pages
- 1688-1694
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2096492292
- Cited by
- 492
- References
- 44
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.